Zhejiang Jolly Pharmaceutical Co Ltd (300181) — Financial Flexibility Index
Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥39.97 Million (operating CF CN¥-23.58 Million minus capex CN¥63.55 Million) represents 0% of total liabilities (CN¥1.46 Billion). Also explore how fast is Zhejiang Jolly Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Jolly Pharmaceutical Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Zhejiang Jolly Pharmaceutical Co Ltd across 19 annual periods. Check 300181 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Jolly Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Zhejiang Jolly Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.48x | CN¥698.95 Million | CN¥411.80 Million | CN¥1.47 Billion | ▼ -0.5% |
| 2024 | 0.48x | CN¥559.94 Million | CN¥297.05 Million | CN¥1.17 Billion | ▼ -3.0% |
| 2023 | 0.49x | CN¥420.18 Million | CN¥288.46 Million | CN¥853.09 Million | ▼ -12.8% |
| 2022 | 0.56x | CN¥496.63 Million | CN¥318.59 Million | CN¥879.19 Million | ▲ +8.1% |
| 2021 | 0.52x | CN¥399.75 Million | CN¥251.80 Million | CN¥765.31 Million | ▲ +16.0% |
| 2020 | 0.45x | CN¥338.04 Million | CN¥279.69 Million | CN¥750.43 Million | ▲ +70.9% |
| 2019 | 0.26x | CN¥169.40 Million | CN¥128.94 Million | CN¥642.86 Million | ▼ -17.6% |
| 2018 | 0.32x | CN¥232.21 Million | CN¥78.28 Million | CN¥726.50 Million | ▲ +61.7% |
| 2017 | 0.20x | CN¥130.90 Million | CN¥6.51 Million | CN¥662.06 Million | ▼ -44.5% |
| 2016 | 0.36x | CN¥201.55 Million | CN¥58.30 Million | CN¥566.00 Million | ▲ +19.9% |
| 2015 | 0.30x | CN¥123.21 Million | CN¥97.13 Million | CN¥414.94 Million | ▲ +73.6% |
| 2014 | 0.17x | CN¥52.99 Million | CN¥13.70 Million | CN¥309.75 Million | ▼ -45.6% |
| 2013 | 0.31x | CN¥53.23 Million | CN¥29.50 Million | CN¥169.38 Million | ▼ -26.4% |
| 2012 | 0.43x | CN¥67.55 Million | CN¥30.51 Million | CN¥158.27 Million | ▼ -8.9% |
| 2011 | 0.47x | CN¥74.98 Million | CN¥13.65 Million | CN¥159.99 Million | ▼ -35.9% |
| 2010 | 0.73x | CN¥103.46 Million | CN¥64.78 Million | CN¥141.47 Million | ▲ +52.1% |
| 2009 | 0.48x | CN¥63.49 Million | CN¥43.89 Million | CN¥132.07 Million | ▲ +44.0% |
| 2008 | 0.33x | CN¥43.66 Million | CN¥31.16 Million | CN¥130.76 Million | ▲ +41.7% |
| 2007 | 0.24x | CN¥25.17 Million | CN¥16.05 Million | CN¥106.79 Million | — |